XORTX Therapeutics (XRTX) Loans - Gross (2020 - 2023)
XORTX Therapeutics' (XRTX) quarterly Loans - Gross came in at $8.2 million in Q1 2023, down 37.25% YoY from $13.1 million in Q1 2022, and down 24.42% on a QoQ basis from $10.9 million in Q4 2022.
XORTX Therapeutics (XRTX) Loans - Gross (2020 - 2023) Analysis & Trends
XORTX Therapeutics (XRTX) has 4 years of Loans - Gross data on file, last reported at $8.2 million in Q1 2023.
- Quarterly Loans - Gross fell 37.25% year-over-year to $8.2 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $8.2 million (down 37.25% YoY) and the FY2022 annual result came in at $11.3 million, down 29.52% from the prior year.
- Loans - Gross slipped to $8.2 million in Q1 2023, from $10.9 million in the prior quarter.
- In the past five years, Loans - Gross ranged from a high of $16.0 million in Q4 2021 to a low of $1.6 million in Q4 2020.
- A 4-year average of $9.6 million and a median of $10.4 million in 2022 frame the typical range for Loans - Gross.
- Annual changes were most pronounced in 2021 — Loans - Gross jumped 914.74% — and 2023, when it sank 37.25%.
- Tracing XRTX's Loans - Gross over 4 years: stood at $1.6 million in 2020, then jumped by 914.74% to $16.0 million in 2021, then slumped by 32.1% to $10.9 million in 2022, then dropped by 24.42% to $8.2 million in 2023.
- The last three Loans - Gross figures came in at $8.2 million (Q1 2023), $10.9 million (Q4 2022), and $9.9 million (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans - Gross (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.29 Bn | 132.43 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.87 Bn | 56.73 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.90 Bn | 10.51 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | - |
| 10 | XORTX Therapeutics | 2.84 Mn | 2.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 8.21 Mn |
| Dec 31, 2022 | 10.87 Mn |
| Sep 30, 2022 | 9.93 Mn |
| Jun 30, 2022 | 10.99 Mn |
| Mar 31, 2022 | 13.09 Mn |
| Dec 31, 2021 | 16.00 Mn |
| Sep 30, 2021 | 6.03 Mn |
| Dec 31, 2020 | 1.58 Mn |